This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Maravai LifeSciences Securities Class Action
Regulatory class action

Maravai LifeSciences Securities Class Action

Analysis based on 19 articles · First reported Mar 06, 2025 · Last updated Mar 16, 2025

Sentiment
-40
Attention
3
Articles
19
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The securities class action lawsuit against Maravai LifeSciences Holdings for alleged financial misstatements is likely to negatively impact its stock price and investor confidence. Investors who suffered losses during the Class Period may seek recovery, potentially leading to significant financial liabilities for Maravai LifeSciences Holdings.

Biotechnology Legal Services
Event Summary

A securities class action lawsuit has been filed against Maravai LifeSciences Holdings by Kessler Topaz Meltzer & Check, on behalf of investors who purchased securities between August 7, 2024, and February 24, 2025. The complaint alleges that Maravai LifeSciences Holdings made materially false and/or misleading statements and failed to disclose adverse facts, including inadequate internal controls over financial reporting, inaccurate revenue recognition in fiscal 2024, and overstated goodwill. The lawsuit was filed in the United States — United States District Court for the Southern District of California, with a lead plaintiff deadline of May 5, 2025. Jonathan Naji is the attorney contact for affected investors.

Key Actions
100 Kessler Topaz Meltzer & Check filed lawsuit Maravai LifeSciences Holdings
90 Maravai LifeSciences Holdings made misleading statements
Entities Involved
stock
Maravai LifeSciences Holdings
Maravai LifeSciences Holdings is the defendant in a securities class action lawsuit, accused of making materially false and/or misleading statements and failing to disclose adverse facts regarding its financial reporting and goodwill.
Importance 100.0 Sentiment -60.0
priv
Kessler Topaz Meltzer & Check
Kessler Topaz Meltzer & Check is a law firm informing investors about the securities class action lawsuit against Maravai LifeSciences Holdings and encouraging affected investors to contact them to potentially become lead plaintiffs.
Importance 80.0 Sentiment 20.0
govactor
United States — United States District Court for the Southern District of California
The United States — United States District Court for the Southern District of California is the venue where the securities class action lawsuit against Maravai LifeSciences Holdings has been filed.
Importance 40.0 Sentiment 0.0
per
Jonathan Naji
Jonathan Naji is an attorney at Kessler Topaz Meltzer & Check, serving as a contact person for investors interested in the Maravai LifeSciences Holdings class action lawsuit.
Importance 30.0 Sentiment 10.0
Relationships
Kessler Topaz Meltzer & Check related ↔ Jonathan Naji
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.